39
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Pharmacokinetics of CAMPATH-1H in BMT patients

, , , , &
Pages 261-267 | Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (12)

Mark Willis & Neil P Robertson. (2014) Drug safety evaluation of alemtuzumab for multiple sclerosis. Expert Opinion on Drug Safety 13:8, pages 1115-1124.
Read now
Raimundo Fernando Bezares, German Stemelin, Alicia Diaz, Daniel Argentieri, Emilio Lanari Zubiaur, Guy Garay, Miguel Bartomioli, Ricardo Ryser & Gustavo Milone. (2011) Multicenter study of subcutaneous alemtuzumab administered at reduced dose in patients with fludarabine-relapsed/refractory chronic lymphocytic leukemia: final analysis. Leukemia & Lymphoma 52:10, pages 1936-1941.
Read now
Xavier Poiré & Koen van Besien. (2011) Alemtuzumab in allogeneic hematopoetic stem cell transplantation. Expert Opinion on Biological Therapy 11:8, pages 1099-1111.
Read now
Steven C Goldstein & David L Porter. (2010) Allogeneic immunotherapy to optimize the graft-versus-tumor effect: concepts and controversies. Expert Review of Hematology 3:3, pages 301-314.
Read now
Thomas Elter, Istvan Molnar, Jens Kuhlmann, Michael Hallek & Clemens Wendtner. (2008) Pharmacokinetics of alemtuzumab and the relevance in clinical practice. Leukemia & Lymphoma 49:12, pages 2256-2262.
Read now
Farhad Ravandi & Susan O'Brien. (2006) Alemtuzumab in CLL and Other Lymphoid Neoplasms. Cancer Investigation 24:7, pages 718-725.
Read now
David Ternant & Gilles Paintaud. (2005) Pharmacokinetics and concentration–effect relationships of therapeutic monoclonal antibodies and fusion proteins. Expert Opinion on Biological Therapy 5:sup1, pages S37-S47.
Read now
Farhad Ravandi & Susan O’Brien. (2005) Alemtuzumab. Expert Review of Anticancer Therapy 5:1, pages 39-51.
Read now
G Kobbe, R Fenk, F Neumann, A Bernhardt, U Steidl, M Kondakci, T Graef, M Aivado, M Vaupel, A-N Huenerlituerkoglu, R Kronenwett, H Pape, B Hildebrand, U Germing & R Haas. (2004) Transplantation of allogeneic CD34+-selected cells followed by early T-cell add-backs: favorable results in acute and chronic myeloid leukemia. Cytotherapy 6:6, pages 533-542.
Read now
N Novitzky, V Thomas, G Hale & H Waldmann. (2004) Campath-1 Abs ‘in the bag’ for hematological malignancies: the Cape Town experience. Cytotherapy 6:2, pages 172-181.
Read now
K RIEGER, U VON GRÜNHAGEN, T FIETZ, E THIEL & W KNAUF. (2004) Efficacy and Tolerability of Alemtuzumab (CAMPATH-1H) in the Salvage Treatment of B-Cell Chronic Lymphocytic Leukemia—Change of Regimen Needed?. Leukemia & Lymphoma 45:2, pages 345-349.
Read now
Francis J Dumont. (2002) CAMPATH (alemtuzumab) for the treatment of chronic lymphocytic leukemia and beyond. Expert Review of Anticancer Therapy 2:1, pages 23-35.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.